![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 7, 5146-5151, February 13, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


||
From the
Department of Physiological Sciences, Martinsried, Munich 82152, Germany,
Max Planck Institute of Biochemistry, Department of Molecular Medicine, Munich 82152, Germany, and ¶Department of Molecular Physiology and Biological Physics, University Virginia, Charlottesville, Virginia 22908-0736
The cGMP-dependent protein kinase (PKG) is the main mediator of nitric oxide-induced relaxation of smooth muscle. Although this pathway is well established, the cellular action of PKG, nitric oxide, and cGMP is complex and not fully understood. A cross-talk between the cGMP-PKG and other pathways (e.g. cAMP-protein kinase A) seems to exist. We have explored cGMP- and cAMP-dependent relaxation of smooth muscle using PKG-deficient mice (cGKI/). In intact ileum strips of wild type mice (cGKI+/+), 8-Br-cGMP inhibited the sustained phase of carbachol contractions by
80%. The initial peak was less inhibited (
30%). This relaxation was associated with a reduction in intracellular [Ca2+] and decreased Ca2+ sensitivity. Contractions of cGKI/ ileum were not influenced by 8-Br-cGMP. EC50 for 8-Br-cGMP for PKG was estimated to be 10 nM. PKG-independent relaxation by 8-Br-cGMP had an EC50 of 10 µM. Relaxation by cAMP (
50% at 100 µM), Ca2+ sensitivity of force, and force potentiation by GTP
S were similar in cGKI+/+ and cGKI/ tissues. The results show that PKG is the main target for cGMP-induced relaxation in intestinal smooth muscle. cGMP desensitize the contractile system to Ca2+ via PKG. PKG-independent pathways are activated at 1000-fold higher cGMP concentrations. Relaxation by cAMP can occur independently of PKG. Long term deficiency of PKG does not lead to an apparent up-regulation of the cAMP-dependent pathways or changes in Ca2+ sensitivity.
Received for publication, June 19, 2003 , and in revised form, October 14, 2003.
* This study was supported by grants from the Swedish Medical Research Council (04x-8268) (to A. A.), The Crafoord Foundation and the Medical Faculty, Lund University (National Institutes of Health Grant PO1 HL19242) (to A. V. S.) and (NIH PO1 HL48807) (to A. P. S.), and Fonds der Chemichen Industrie (to R. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|| Present address and to whom correspondence should be addressed: Dept Physiological Sciences, Lund University, BMC F11, SE-221 84 Lund, Sweden. Tel.: 46-46-222-7758; Fax: 46-46-222-7765; E-mail: Anders.Arner{at}mphy.lu.se.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Weber, D. Bernhard, R. Lukowski, P. Weinmeister, R. Worner, J. W. Wegener, N. Valtcheva, S. Feil, J. Schlossmann, F. Hofmann, et al. Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle Specific Expression of Either Isozyme Circ. Res., November 26, 2007; 101(11): 1096 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vanneste, I. Dhaese, P. Sips, E. Buys, P. Brouckaert, and R. A. Lefebvre Gastric motility in soluble guanylate cyclase {alpha}1 knock-out mice J. Physiol., November 1, 2007; 584(3): 907 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Azam, K. Yoshioka, S. Ohkura, N. Takuwa, N. Sugimoto, K. Sato, and Y. Takuwa Ca2+-Independent, Inhibitory Effects of Cyclic Adenosine 5'-Monophosphate on Ca2+ Regulation of Phosphoinositide 3-Kinase C2{alpha}, Rho, and Myosin Phosphatase in Vascular Smooth Muscle J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Worner, R. Lukowski, F. Hofmann, and J. W. Wegener cGMP signals mainly through cAMP kinase in permeabilized murine aorta Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H237 - H244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Kruger, S. J. Peterson, M. L. Schwartzman, H. Fusco, J. A. McClung, M. Weiss, S. Shenouda, A. I. Goodman, M. S. Goligorsky, A. Kappas, et al. Up-Regulation of Heme Oxygenase Provides Vascular Protection in an Animal Model of Diabetes through Its Antioxidant and Antiapoptotic Effects J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1144 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Alemany, O. Vogler, S. Teres, C. Egea, C. Baamonde, F. Barcelo, C. Delgado, K. H. Jakobs, and P. V. Escriba Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase J. Lipid Res., August 1, 2006; 47(8): 1762 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zeng, S. Zhuang, J. Gloddek, C.-C. Tseng, G. R. Boss, and R. B. Pilz Regulation of cGMP-dependent Protein Kinase Expression by Rho and Kruppel-like Transcription Factor-4 J. Biol. Chem., June 23, 2006; 281(25): 16951 - 16961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ekman, K. Fagher, M. Wede, K. Stakeberg, and A. Arner Decreased Phosphatase Activity, Increased Ca2+ Sensitivity, and Myosin Light Chain Phosphorylation in Urinary Bladder Smooth Muscle of Newborn Mice J. Gen. Physiol., January 31, 2005; 125(2): 187 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bonnevier and A. Arner Actions Downstream of Cyclic GMP/Protein Kinase G Can Reverse Protein Kinase C-mediated Phosphorylation of CPI-17 and Ca2+Sensitization in Smooth Muscle J. Biol. Chem., July 9, 2004; 279(28): 28998 - 29003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |